LIVING-RELATED PEDIATRIC KIDNEY TRANSPLANTATION IN CHINA, A SINGLE CENTER EXPERIENCE.

C. Wang,L. LIU,J. LI,L. CHEN,S. DENG,J. FEI,J. QIU,Q. fu

DOI: https://doi.org/10.1097/00007890-201007272-02103

2010-01-01

Transplantation

Abstract:Wang, C.; LIU, L.; LI, J.; CHEN, L.; DENG, S.; FEI, J.; QIU, J.; fu, Q. Author Information

What problem does this paper attempt to address?

Living Related Kidney Transplantation in China: A Single Center'S Experience of 1008 Cases

T. Song,L. Wang,Z. Huang,L. Fu,D. Zeng,Z. Rao,L. Xie,X. Wang,T. Lin

DOI: https://doi.org/10.1097/00007890-201407151-00777

2014-01-01

Transplantation

Abstract:Objective China is in the process to increase the supply of organs and to make their organ donation and transplantation comply with the WHO guiding principle. As the leading living related kidney transplant (LRKT) center, we adhered strictly to the government regulations and performed over 1000 cases of LRKT during last 8 years. Methods We retrospectively reviewed the medical file of 1008 LRKT from Jan 1st 2006 to Sep 30th 2013. All clinically important items were summarized. Results There were 346 male donors and 748 (74.2%) male recipients. Donor's age was 46.68±9.81y (18-66). Recipients' age was 33.11±8.85y (11-65), height 165.84±6.69cm (145-194), weight 58.71±9.97kg (28-96).The pre-transplant dialysis period was 10.14±12.21 months(0-96). HLA matching was 3.32±1.25 and PRA was 3.14±10.08%(0-99%).Mean follow up was 34.82±21.86 months (4-93). During the follow up, 27 (2.67%) cases were lost. 303 cases received induction therapy (anti-thymocyte globulin: 46, anti-CD25 monoclonal antibody: 257). The majority of patients received triple immunosuppressant (CNI: cyclosporine A(CSA)/tacrolimus (TAC), MMF, prednisone) as maintenance immunosuppression. CSA was initiated in 289 cases and TAC in 719 cases. 50 case converted CNI to sirolimus once, but only 14 cases currently maintained with sirolimus. 29 (2.9%) graft failure occurred and 8 year death-censored graft survival was 92.8%. 19 (1.9%) patients died and 8 year patients' survival was 97.3%. There was 18 (1.8%) delayed graft function and all cases recovered. Acute rejections occurred in 126 (12.5%) cases.24 (2.4%) reoperations were performed, of which 6 due to massive bleeding. There was 6 (0.6%) urinary leakage and 64 (6.3%) lymphatic leaks. There was 255 (25.3%) post-transplant infection and 13 infections resulted in death.9 (0.9%) cases developed new onset diabetes and femoral head necrosis occurred in 5 (0.5%) cases. Two to three years after transplantation, 3 (0.2%) cases detected malignancy. Conclusion The outcome of LRKT in our center is excellent. Meanwhile, as a practice ethically accepted by international transplant community, LRKT should be encouraged in China.
Outcome of Single Kidney Transplant from Pediatric Donors Younger Than 5 Years of Age after Cardiac Death in China: A Single Center Experience

Yaomin Wang,Junhao Lv,Wenqing Xie,Hongfeng Huang,Wenhan Peng,Jianyong Wu,Jianghua Chen

DOI: https://doi.org/10.6002/ect.2014.0177

2015-01-01

Experimental and Clinical Transplantation

Abstract:OBJECTIVES:This study was conducted to evaluate the outcomes of single kidney transplant from pediatric donors in China younger than 5 years old after cardiac death.MATERIALS AND METHODS:We retrospectively reviewed single renal transplants from pediatric donors of cardiac death between January 2012 and June 2013 at the First Affiliated Hospital of Zhejiang University, China.RESULTS:Eleven recipients received single kidney transplant from 6 pediatric donors of cardiac death donors at our center (aged, < 5 years). The median donor age was 39 months (range, 17-56 mo). The median donor weight was 14.5 kg (range, 11-20 kg). While the median recipient age was 35 years (range, 12-55 y). The median recipient weight was 42.5 kg (range, 21-55 kg). The recipient serum creatinine level gradually decreased and the 1-year serum creatinine was 77.7 ± 17.6 μmol/L. Delayed graft function occurred in 5 recipients (45.5%), and all of them recovered within 1 month after transplant. No episodes of acute rejection occurred. No vascular thrombosis or stenosis after ureteroneocystostomy was seen. One patient had urine leakage on the eighth day after transplant, and was cured through a ureter reimplantation. The graft size increased significantly the first month after transplant compared with that recorded immediately after reperfusion (P = .011). The 1-year patient/graft survival was 100%.CONCLUSIONS:Use of single kidney from pediatric donors after cardiac death (aged, < 5 y) is a safe and effective procedure and can greatly expand the donor pool.
LONG-TERM OUTCOME OF SIMULTANEOUS AND STAGED KIDNEY TRANSPLANT AND URINARY DIVERSION: EXPERIENCE OF SINGLE CENTER

L. Teng,C. Wang,L. LIU

DOI: https://doi.org/10.1097/00007890-201007272-01779

2010-01-01

Transplantation

Abstract:1Department Of Organ Transplantation, First Affiliated Hospital, Sun Yat-sen University, Guangzhou/Guangdong/CHINA, 2Department Of Organ Transplantation, First Affiliated Hospital, Sun Yat-sen University, Guangzhou/CHINA, 3Transplantation Center, the First Affiliated Hospital of Zhongshan University, Guangzhou/CHINA
Liver Transplantation in Patients with Liver Failure: Twenty Years of Experience from China

Sunbin Ling,Guangjiang Jiang,Qingyang Que,Shengjun Xu,Junli Chen,Xiao Xu

DOI: https://doi.org/10.1111/liv.15288

IF: 8.754

2022-01-01

Liver International

Abstract:Liver transplantation (LT) is the only effective method of treating end-stage liver disease, such as various types of liver failure. China has the largest number of patients with hepatitis B virus-related disease, which is also the main cause of liver failure. From the first LT performed in 1977, and especially over the past two decades, LT has experienced rapid development as a result of continuous research and innovation in China. China performs the second-highest number of LTs every year worldwide, and the quality of LT continues to improve. Starting January 1, 2015, all donor's livers have been from deceased donors and familial donors. Thus, China entered into a new era of LT. However, LT is still a challenging procedure in China. In this review, we introduced the brief history of LT in China, the epidemiology, aetiology and clinical outcomes of LT for liver failure in China and summarized the experience of LT from Chinese LT surgeons and scholars. The future perspectives of LT were also discussed, and it is expected that China's LT research could be further integrated elsewhere in the world.
Pediatric Kidney Transplantation in China: an Analysis from the IPNA Global Kidney Replacement Therapy Registry

Shen Qian,Fang Xiaoyan,Man Xinyue,Zhai Yihui,Liu Longshan,Wang Changxi,Shang Wenjun,Feng Guiwen,Zhang Lei,Zeng Li,Zhu Youhua,Chen Jing,Rao Jia,Warady Bradley A,Schaefer Franz,Xu Hong

DOI: https://doi.org/10.1007/s00467-020-04745-7

2020-01-01

Pediatric Nephrology

Abstract:The International Pediatric Nephrology Association (IPNA) Global Kidney Replacement Therapy (KRT) Registry was established to evaluate the incidence and outcomes of kidney replacement therapy (dialysis and transplantation) provided to children worldwide. Analysis of registry data for separate regions is feasible. Three centers located in Shanghai, Guangzhou, and Zhengzhou, which have the greatest number of pediatric kidney transplantation cases in China, participated in this analysis of transplant data. Data were registered by each center for patients under the age of 19 years who received a single-organ kidney transplant for the first time between 2011 and 2018. In total, 415 patients (59.8% male) aged 1.4–18.7 (median 12.1) years were followed for 0.3–97.1 (median 27.7) months. The number of kidney transplants increased from a total of 129 during 2011–2014 to 286 cases during 2015–2018. 85.8% of patients received the transplanted kidney from a pediatric (age < 19 years) donor, and deceased donors accounted for 94% of all donors. 8.0% of grafts were lost. One and 5-year patient survival rates were 97.6% and 95.5%, respectively. The major cause of death was infection (7/14). Similar graft and patient survival rates were observed for organs from pediatric and adult donors in 6–11 and 12–18 year recipient age groups, whereas recipients < 6 years showed inferior patient and graft survival. Pediatric kidney transplantation shows favorable short-term and medium-term outcomes in China. Our experience supports use of pediatric donors in pediatric kidney transplantation, but attention directed to the outcome of recipients aged under 6 is necessary.
Twenty-nine Years Experience of Kidney Transplantation from Zhejiang University.

Jianghua Chen,Lihui Qu,Jianyong Wu,Yiming Wang,Jianguo Zhang,Zhangfei Shou,Huiping Wang,Hongfeng Huang,Qiang He,Ping Zhang,Xiaohui Zhang,Zong Zhu

2005-01-01

Abstract:During the last 29 years the dramatic changes that have taken place in our transplant programs and in solid organ transplantation permit us to face tomorrow with courage and confidence. In the future we will be deeply concerned that the long-term benefit of more effective immunosuppression or novel strategies might be unfavorably impacted by the tendency to use organs whose intrinsic lifespan may be limited. We are deeply concerned by the inexorably increasing discrepancy between supply and demand for deceased kidneys, especially for the added morbidity that this inevitably entails for those patients with ESRD who do not have live donors. Our program continues to seek better ways to improve survival and the quality of the life of our patient population.
Pediatric renal transplantation: clinical analysis of 23 cases]

Jiang-hua Chen,Wei Shen,Qiang He,Rui Jiang,Wen-han Peng

DOI: https://doi.org/10.3760/j.issn.0529-5815.2004.18.004

2004-01-01

Abstract:To study the clinical characters and the therapeutic experience of pediatric kidney transplantation.Clinical data of 23 pediatric renal transplant recipients (less than 18 years, 14 boys, 9 girls) were analyzed. Recipients were 11 - 17 (mean 15.4 +/- 1.0 years) years old at transplantation. The kidneys were transplanted en bloc extraperitoneally into the recipient's iliac fossa, with the donor renal vein anastomosed to the recipient's external iliac vein. Among 23 transplant procedures, the donor renal artery was anastomosed to the external iliac artery in 14 cases, to the internal iliac artery in 4 cases and to the common iliac artery in 3. The other two allografts were unusual. All the patients were treated with cyclosporine or tacrolimus based immunosuppression, including steroid and azathioprine or mycophenolate mofetil. The initial dose of cyclosporine was 6 - 7 mg per kilogram of body weight per day and that of tacrolimus was 0.15 - 0.20 mg per kilogram of body weight per day. The data of the recovery of renal function, rejection episodes, incidences of side effect and related complication were analyzed respectively.The transplantation operations were performed uneventful in all the 23 recipients. There were no graft losses for technical reasons. The single graft failure was the result from bad compliance. The renal function was improved 5.5 days in average after transplantation in 22 cases. Main complications were arterial hypertension (57%), pulmonary infection (13%), drug-induced hepatic injury (13%) and bone marrow suppression (13%). Acute rejection occurred in 4 persons 1 year post-operatively (17%). The body weight of the recipients increased 2.3 kg in average and height increased 1.0 cm after the first post-operative year. The mean duration for follow-up was 42 month. One-year patient/graft survival rate was 100%/96% and three-year patient/graft survival rate was 90%/80%.Kidney transplantation is the preferred treatment for end stage renal failure in children patient. The well procedure, reasonable immunosuppressive regime, prevention and prompt therapy of complication are the keys to get satisfactory survival rate of human/kidney.
Marginal Living Donor in Kidney Transplantation: Experience in a Chinese Single Center.

Li Gang,Wang Yun-peng,Ma Lu-lin,Zhang Jing,Zhang Hong-xian,Huang Yi,Hou Xiao-fei,Xiao Chun-lei,Zhao Lei,Wang Guo-liang,Tian Xiao-jun,Qiu Min,Zheng Yi

DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.20130454

2013-01-01

Abstract:Background Living donor kidney transplantation is becoming popular in China, whereas, in clinical situations, some kidney donors may be sub-optimal, namely marginal living donor. The present study aimed to evaluate the safety and efficacy of marginal living donor kidney transplantation in a Chinese single center. Methods Between January 2001 and December 2009, 888 kidney transplantations were performed in our center; 149 were living donor kidney transplantations. The living donors and recipients were followed up regularly after the operation. Of the living donors, 30 donors were marginal, who were older than 60 years or suffered from kidney anomaly or some benign diseases. Among the non-marginal living kidney transplantations, 58 donors and recipients had complete perk operative and follow-up data. We compared the marginal and non-marginal living donor kidney transplantations with regard to donor age, follow-up period, donor's serum creatinine at the last follow-up, recipient's serum creatinine at the last follow-up, and graft survival at the last follow-up. Results The mean age of donors in the marginal and non-marginal living donors were (55 +/- 9) (37-66) and (43 +/- 12) (30-59) years. The mean follow-up times of the marginal and non-marginal groups were (26.4 +/- 13.4) months and (28.8 +/- 14.8) months. The donor and recipient serum creatinine levels at the last follow-up were (1.16 +/- 0.20) mg/dl and (1.30 +/- 0.24) mg/dl in the marginal group, and (1.12 +/- 0.32) mg/dl and (1.34 +/- 0.32) mg/dl in the non-marginal group. Three recipients in the marginal group and five recipients in the non-marginal group had acute rejection episodes during the first year. Actuarial 3-year graft survival was 96.7% in the marginal group and 100% in the non-marginal group. No significant differences were detected between the two groups with regard to these data. Conclusion Utilization of highly selective marginal living donors can be a safe, feasible, and effective way for the treatment of patients with end stage renal disease.
Reduced Size Living-Related Liver Transplantation in Child:Case Report

史宪杰,窦科峰,李开宗,管文贤,高志清,傅由池,朱庆生,张英民,赵青川,岳树强,王德盛,张新海

DOI: https://doi.org/10.3760/cma.j.issn.0253-3006.1999.02.007

1999-01-01

Abstract:Objective To review the technicality of living-related,reduced size pediatric liver transplant.Methods The authors successfully performed a living-related liver transplantation in June.1997.The recipient was a 10-year-old girl(weight 24 kg,height 121 cm)with Caroli's disease and recurrent cholangitis.The donor was her father who aged 40 years.The left lateral segment(segments Ⅰ and Ⅱ)was used for the graft.Transection was mapped by intra-operative ultrasound.The parenchymal resectionwas carried out with an ultrasound dissector and double electro-coagulator without vascular occlusion.The warm ischaemic time was zero.Results The donor had no operative complication.The early comaplications of the recipient were effectively managed.Conclusions Successful donor hepatectorny is crucial in living related liver transplant.The initial success is promising for the future of pediatric liver transplantation in China.
MICROSURGICAL RECONSTRUCTION OF ANATOMICALLY VARIANT RENAL GRAFT ARTERIES WITH THE RECIPIENTʼS VESSELS IN LIVING-RELATED KIDNEY TRANSPLANTATION.

C. Wang,L. LIU,L. CHEN,S. DENG,J. FEI,J. QIU,J. LI,L. Teng

DOI: https://doi.org/10.1097/00007890-201007272-01127

2010-01-01

Transplantation

Abstract:Wang, C.1; LIU, L.2; CHEN, L.3; DENG, S.4; FEI, J.4; QIU, J.3; LI, J.4; Teng, L.5 Author Information
Pediatric kidney transplantation, a technical update

Kambiz Etesami,Rachel Hogen,Rachel Lestz

DOI: https://doi.org/10.1097/MOT.0000000000000898

2021-08-01

Abstract:Purpose of review: Pediatric kidney transplantation is the definitive therapy for infants and children suffering from renal failure. It is a distinct endeavor demanding specialized care for optimal results. This includes a dedicated preoperative workup accounting for unique predisposing urologic conditions, specialized surgical techniques, and careful hemodynamic monitoring and maintenance. Recent findings: Historically, size-matched renal allografts from pediatric donors to pediatric recipients suffered from poor outcomes. Advances in surgical technique performed at high volume centers have shown that these operations can be performed safely, helping expand the donor pool for these patients. Concurrently, transplantation of increasingly small for size infants with complex medical and surgical backgrounds has become a reality. Summary: On a policy front, efforts to expand access to size-matched organs, combined with advances in medical management and immunosuppression have seen pediatric renal transplantation reach new heights. Now, these breakthroughs are heightened by the ability to transplant such organs into the smallest infants. The net result will be diminished transplant waiting times and, accordingly, improved quality of life and longevity for children suffering from renal failure.
Safety Analysis of Living Related Live Donors in Kidney Transplantation

CHEN Zheng,PAN Guang-hui,LIAO De-huai,FANG Jia-li,LI Guang-hui,CHEN Jian-bing,ZHANG Shan-bin,ZHAO Yu-bo,SHI Bing-yi

DOI: https://doi.org/10.3321/j.issn:1000-6702.2008.05.008

2008-01-01

Abstract:Objective To analyze the clinical outcomes and evaluate the safety of living related live donors in kidney transplantation.Methods One hundre and thirty-two cases of living related donors were studied retrospectively for psychological and physiological parameters. The parameters including life quality, urinalysis, serum biochemistry tests, glomerular filtration rate (GFR) and endogenous creatinine clearance rate (CCr) were analyzed.Results There was no significant difference between living related donors and normal people in the aspect of life quality. In living related donors,SCr was (78.33±15.94)μmol/L before operation and was (108.49±19.88)μmol/L at 7 days postoperation, P＜0.05. SCr was (112.47±20. 38)μmol/L at 6 months post-operation. There was no significant difference in SCr levels between 7 days and 6 months post-operation (P=0. 109). CCr was (95.80±20.92)ml/min in pre-operation and was (57.36±14. 92)ml/min at 7 days post-operation,P＜0.05. CCr was (65. 49±8. 25) ml/min at 6 months post-operation. There was no significant difference in CCr between 7 days and 6 months post-operation.The pre-operative total GFR was(74.08±18.51)ml/min. Of which, the right kidney GFR was (38.43±10.33)ml/min. The residual right kidney GFR was (56. 49±13. 01 ) ml/min 6 months after operation, which decreased 17. 59 ml/min (23.8%) compared with pre-operative total GFR (P＜0.05) and increased 18. 06 ml/min (47.0%) compared to the pre-operative right kidney GFR. Surgical complications included 1 case of splenectomy, 1 case of descending colon rupture and 5 cases of wound fat liquefactions.Conclusion Pre-operatively systemic psychological and physiological evaluation on living related donors, detailed consent consultation, standardized operating techniques, careful perioperative management and strict follow-up can improve the safety of living related donors.
Living Related Donor Kidney Transplantation after Resection of a Small Renal Cancer: Case Report and Review of the Literature

Wang Jina,Zheng Long,Jia Yichen,Qi Guisheng,Xu Ming,Rong Ruiming,Zhu Tongyu

DOI: https://doi.org/10.3877/cma.j.issn.1674-3903.2017.01.003

2017-01-01

Abstract:Objective To summarize the experience and key points of living relative kidney transplantation after resection of a small renal cancer.Methods Retrospective analysis was performed on the clinical data and postoperative outcome of a case of living relative kidney transplantation after resection of a small cancer January 2016 in Zhongshan Hospital, Fudan University.The donor was the mother of recipient, CT angiography showed that there was a round spot (16 mm×15 mm) on the bottom of right kidney which was thought to be small renal carcinoma.Donor kidney was harvested through 11th-rib supracostal incision.Then it was washed and perfused with preservation solution.The tumor in the living donor kidney was resected and sent for intra-operational pathological examination and the tumor-resected kidney was subsequently used for kidney transplantation after no edge infiltration was confirmed.Results Post-operative pathological examination showed that the histologic type of the tumor was clear cell carcinoma and no carcinoma tissue was found in renal capsule.Basiliximab was used to immunosuppression induction before bloodstream was opened intranperative and 4 days after operation.The immunosuppressive therapy included tacrolimus+mycophenolate+prednisolone in 3 months after operation and tacrolimus switched to rapamycin later.Besides the regulatory examination, the recipient also received doppler ultrasound examination.The recipient was followed for 6 months until July 2016.No space-occupying lesion was found during follow-up and the function of the transplant kidney was stable.Conclusions With strict assessment and pathological confirmation, donor kidneys with a small cancer, once resected, can serve as a donor kidney in transplantation with good expectations.This may become an effective approach in increasing the source of donor kidney.
Living Related Kidney Transplantation:A Report of 25 Cases

马潞林,管德林,韩修武,高居忠,韩志友,李响,张愚,刘静,李晓北,王建文,张鹏

DOI: https://doi.org/10.3760/j:issn:1000-6702.2001.12.005

2000-01-01

Abstract:Objective To evaluate the efficacy of living related kidney transplants (LRKT). Methods Retrospectively clinical results of 25 LRKT were reviewed and analyzed. Results Living related donors underwent nephrectomy without any complications and the donors have had normal renal function on follow up studies.All the renal grafts survived.Two recipients experienced delayed graft function recovery,Both the patients and the grafts have been surviving. Conclusions The patient and graft survival rates of LRDT are better than cadaveric donor transplantation.Living related donor serves as an alternate way of kidney source.
Kidney Transplantation from Small Pediatric Donors May Be Feasible to Those Who Developed Chronic Refractory Dialysis Hypotension: a Single-Center Experience.

Lu Zheng,Hanying Jia,Rending Wang,Wenhan Peng,Junhao Lv,Wenhua Lei,Guangjun Liu,Yu Cui,Jianghua Chen,Jianyong Wu

DOI: https://doi.org/10.21037/atm-20-304

IF: 3.616

2020-01-01

Annals of Translational Medicine

Abstract:BACKGROUND:Chronic refractory dialysis hypotension (CRDH) is a serious issue in dialysis patients waiting for transplants. It leads to fatal clinical outcomes and disqualification from kidney transplantation. Kidney transplantation from pediatric donor to adult patient with lower blood pressure (BP) may be an option. No related study has been reported and we conducted this study to first evaluate the effect of pediatric donor kidney transplantation in CRDH recipients.METHODS:Ten single-kidney transplantations from small pediatric donors after cardiac death in our center between August 2016 and April 2018 were described. Half were CRDH recipients (group A) with intradialytic and interdialytic systolic blood pressure (SBP) below 100 mmHg. Each was paired with no-CRDH recipient (control, group B) from the same donor. The operation method of vascular anastomosis and ureterocystoneostomy was the same as that of adult donors. Clinical characteristics, post-operative treatment and outcomes of all recipients were retrieved. Postoperative BP, graft function and size were compared between two groups. The follow-up time was up to April 2019.RESULTS:There was no acute rejection (AR), graft loss or death in all recipients after transplantation. Their renal function was recovered despite three transient delayed graft function (DGF). There was no significant difference in serum creatinine (SCr) or graft size (P=0.84, 0.94) after transplantation between two groups. For all CRDH recipients, the postoperative SBP was above 100 mmHg (except one, 90-130 mmHg). The BP one year after transplantation was maintained at 110-125/70-85 mmHg.CONCLUSIONS:kidney transplantation from small pediatric donors may be feasible to CRDH recipients and their BP may return to normal after transplantation.
Retroperitoneoscopic Live-donor Right Nephrectomy: A Chinese Single Center

Lulin Ma,Gang Li,Yi Huang,Xiaofei Hou,Lei Zhao,Guoliang Wang,Xiaojun Tian,Wenhao Tang,Yingtao Chen

2011-01-01

Experimental and Clinical Transplantation

Abstract:Objectives: To evaluate our right-retroperitoneoscopic live-donor nephrectomy by comparing the left side with the right side, and reporting our single-center experience for right-retroperitoneoscopic live-donor nephrectomy. Patients and Methods: In China, live-kidney transplant is limited. It is even more essential now, because the deceased-donor kidney has become fewer after enacting the Chinese Regulation on Human Organ Transplantation. Therefore, there is a continued need to use the limited live-donor population. We chose 103 consecutive cases (84 left and 19 right) that underwent retroperitoneoscopic live-donor nephrectomy between December 2005 and December 2009, to compare the intraoperative and postoperative characteristics between the left and right sides, and report our experiences for 19 right-retroperitoneoscopic live-donor nephrectomies. Results: All 84 left and 19 right-retroperitoneoscopic live-donor nephrectomies were accomplished successfully without open conversion and transfusion. No significant differences were observed between the 2 groups regarding operative time, warm ischemia time, estimated blood loss, length of hospital stay, and serum creatinine level at discharge (Table 1). Eight of the donors and 3 of the grafts had minor complications that were all resolved with conservative treatment. The recipients' serum creatinine levels at 1 day and 1 month after surgery were the same in both groups. No acute renal tubule necrosis or delayed graft function was observed in the recipients. Conclusions: Our right-retroperitoneoscopic live-donor nephrectomy achieves comparable outcomes with the left side and proves to be a feasible, cost-effective, safe, and minimally invasive alternative for live-kidney donation. This maximally uses the innately limited donors and potentially increases the donor pool in China.
Transplantation of Kidneys from Small Pediatric Donors into Pediatric Recipients

L. Zhang,W. Zhao,L. Zeng,Y. Zhu,Q. Shen,H. Xu

DOI: https://doi.org/10.3760/cma.j.issn.0254-1785.2016.01.001

2016-01-01

Abstract:Objective To investigate the clinical features of kidney transplantation of small pediatric donors to pediatric recipients.Method A retrospective analysis of 48 kidney transplants from small pediatric donors into pediatric recipients was performed.Result Based on the transplantation types,the patients were divided into two groups:the single kidney transplantation (SKT) group and the en bloc kidney transplantation (EBKT) group.SKT was performed on 36 patients and EBKT on 12 patients.In the SKT group,postoperative complications included vascular thrombosis in 1 case (2.8％),primary disease recurrence in 1 case (2.8％),ureteral stenosis in 1 case (2.8％),delayed graft function in 17 cases (47.3 ％) and acute rejection in 4 cases (11.1 ％).In the EBKT group,postoperative complications included vascular thrombosis in 4 cases (33.3％),urine leak in 2 cases (16.7％),delayed graft function in 2 cases (16.7％) and acute rejection in 2 cases (16.7％).At last follow-up,patient survivals were 100％ in both groups,whereas graft survival was 94.4％ (34/36) in the SKT group and 75％ (9/12) in the EBKT group.The mean serum creatinine in the SKT and EBKT group was (68.4 ± 22.1) and (55.8 ± 16.7) μmol/L,respectively.Conclusion Favorable outcomes can be obtained from transplantation from small pediatric donors.The use of this donor population for pediatric recipients should be encouraged.
Pediatric hematopoietic stem cell transplantation in China: Data and trends during 1998–2012

hong du,jing chen,maoquan qin,jianpei fang,zhiguang li,yiping zhu,xin sun,dongsheng huang,jie yu,yongmin tang,shaoyan hu,junhui li,zhiquan zhang,zuo luan

DOI: https://doi.org/10.1111/petr.12525

2015-01-01

Pediatric Transplantation

Abstract:The success of treating a wide variety of pediatric diseases with HSCT, hematologic malignancies in particular, has resulted in an increased number of long-term survivors. This study is the first large-scale, multicentre report that describes the evolution of pediatric HSCTs in China during the period of 1998-2012. Of all 1052 patients, 266 cases were treated with autologous HSCs and 786 used allogeneic HSCs. The disease indications for HSCTs mainly included leukemias, lymphoma, solid tumors, and non-malignant disorders. The total number of HSCTs, especially unrelated donor transplants, appeared to be increasing year by year. For patients with neuroblastoma, the therapeutic efficacy seemed to be poor, with a five-yr OS and DFS rate of 34.5 +/- 14.3% and 20.7 +/- 9.6%, respectively. In contrast, the survival of patients with SAA was prominently improved, and their five-yr OS and DFS rates were 82.8 +/- 4% and 80.7 +/- 4.1%, respectively. Patients who received cord blood transplants had a lower incidence of acute GVHD than that of PB and/or BM transplants from unrelated donors. This report offers us a valuable resource for evaluating the changes in HSCTs in China over the past 14yr.
Abo-Incompatible Living Kidney Transplantation

Menger Cen,Rending Wang,Weiwei Kong,Hao Deng,Wenhua Lei,Jianghua Chen

DOI: https://doi.org/10.1111/ctr.14050

2020-01-01

Clinical Transplantation

Abstract:ABO-incompatible living kidney transplantation is nowadays a routine procedure to expand living donor pool. The past decades have seen the evolution of desensitization protocol and immunosuppression regimen. Despite increased bleeding events, infectious complications, and rejection episodes reported in some studies, favorable graft and patient survival rate are now achieved, regardless of various protocols among transplant centers. Several issues such as the usage of rituximab and standardization of blood group antibody titration remain to be settled. The deposition of C4d is no longer the histopathologic hallmark of antibody-mediated rejection, which have inspired innovative strategies of peripheral molecular screening and the improvement of histological diagnosis of AMR (antibody-mediated rejection). The better understanding of the underlying mechanism might facilitate the distinction and therapeutic schemes of AMR.
Preliminary experience of parental living transplantation for hepatoblastoma in children

Yang Zhen-yu,Chen Fu-zhen,Li bin

DOI: https://doi.org/10.3969/j.issn.1671-6353.2007.02.011

2007-01-01

Abstract:Objective To summarize and evaluate the experience of living-related party liver transplantation for hepatoblastoma in children.Methods Living-related liver transplantation was performed on a 4-year old child with hepatoblastoma,and the left lateral lobe graft was taken from his mother in July 2004.Results The donor discharged from hospital after 7 days;22 days later,the recipient recovered satisfactorily without occurrence of any complication,now the child has good life quality during a follow-up of 24 months.Conclusions LRLT,a new source for liver graft,the therapeutic pathway could be effective used in treating the children with end stage liver disease,such as hepatoblastom.

LIVING-RELATED PEDIATRIC KIDNEY TRANSPLANTATION IN CHINA, A SINGLE CENTER EXPERIENCE.

Living Related Kidney Transplantation in China: A Single Center'S Experience of 1008 Cases

Outcome of Single Kidney Transplant from Pediatric Donors Younger Than 5 Years of Age after Cardiac Death in China: A Single Center Experience

LONG-TERM OUTCOME OF SIMULTANEOUS AND STAGED KIDNEY TRANSPLANT AND URINARY DIVERSION: EXPERIENCE OF SINGLE CENTER

Liver Transplantation in Patients with Liver Failure: Twenty Years of Experience from China

Pediatric Kidney Transplantation in China: an Analysis from the IPNA Global Kidney Replacement Therapy Registry

Twenty-nine Years Experience of Kidney Transplantation from Zhejiang University.

Pediatric renal transplantation: clinical analysis of 23 cases]

Marginal Living Donor in Kidney Transplantation: Experience in a Chinese Single Center.

Reduced Size Living-Related Liver Transplantation in Child:Case Report

MICROSURGICAL RECONSTRUCTION OF ANATOMICALLY VARIANT RENAL GRAFT ARTERIES WITH THE RECIPIENTʼS VESSELS IN LIVING-RELATED KIDNEY TRANSPLANTATION.

Pediatric kidney transplantation, a technical update

Safety Analysis of Living Related Live Donors in Kidney Transplantation

Living Related Donor Kidney Transplantation after Resection of a Small Renal Cancer: Case Report and Review of the Literature

Living Related Kidney Transplantation:A Report of 25 Cases

Kidney Transplantation from Small Pediatric Donors May Be Feasible to Those Who Developed Chronic Refractory Dialysis Hypotension: a Single-Center Experience.

Retroperitoneoscopic Live-donor Right Nephrectomy: A Chinese Single Center

Transplantation of Kidneys from Small Pediatric Donors into Pediatric Recipients

Pediatric hematopoietic stem cell transplantation in China: Data and trends during 1998–2012

Abo-Incompatible Living Kidney Transplantation

Preliminary experience of parental living transplantation for hepatoblastoma in children